1,892
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Current Research Describing the Role of CD4+ T Lymphocyte Subsets in the Pathogenesis of Granulomatous Lobular Mastitis

, , , &
Pages 1790-1795 | Received 05 Apr 2022, Accepted 09 Jun 2022, Published online: 08 Sep 2022

References

  • Velidedeoglu M, Umman V, Kilic F, et al. Idiopathic granulomatous mastitis: introducing a diagnostic algorithm based on 5 years of follow-up of 152 cases from Turkey and a review of the literature. Surg Today. 2022;52(4):668–680. doi:10.1007/s00595-021-02367-6.
  • Huang YM, Lo C, Cheng CF, Lu CH, Hsieh SC, Li KJ. Serum C-reactive protein and interleukin-6 levels as biomarkers for disease severity and clinical outcomes in patients with idiopathic granulomatous mastitis. JCM. 2021;10(10):2077. doi:10.3390/jcm10102077.
  • Kessler E, Wolloch Y. Granulomatous mastitis: a lesion clinically simulating carcinoma. Am J Clin Pathol. 1972;58(6):642–646. doi:10.1093/ajcp/58.6.642.
  • Brown KL, Tang PH. Postlactational tumoral granulomatous mastitis: a localized immune phenomenon. Am J Surg. 1979;138(2):326–329. doi:10.1016/0002-9610(79)90397-0.
  • Karanlik H, Ozgur I, Simsek S, et al. Can steroids plus surgery become a first-line treatment of idiopathic granulomatous mastitis. Breast Care (Basel). 2014;9(5):338–342. doi:10.1159/000366437.
  • Mizrakli T, Velidedeoglu M, Yemisen M, et al. Corticosteroid treatment in the management of idiopathic granulomatous mastitis to avoid unnecessary surgery. Surg Today. 2015;45(4):457–465. doi:10.1007/s00595-014-0966-5.
  • Hovanessian Larsen LJ, Peyvandi B, Klipfel N, Grant E, Iyengar G. Granulomatous lobular mastitis: imaging, diagnosis, and treatment. AJR Am J Roentgenol. 2009;193(2):574–581. doi:10.2214/AJR.08.1528.
  • Papila Kundaktepe B, Velidedeoğlu M, Mete B. The effect of methotrexate monotherapy on treatment-resistant idiopathic granulomatous mastitis patients. Surgeon. 2021;20(3):e13–e19. doi:10.1016/j.surge.2021.03.001.
  • Luo W, Xu B, Wang L, et al. Clinical characteristics and predictive factors of erythema nodosum in granulomatous lobular mastitis. Aust J Dermatology. 2021;62(3):342–346. doi:10.1111/ajd.13640.
  • Parperis K, Achilleos S, Costi E, Vardas M. Granulomatous mastitis, erythema nodosum and arthritis syndrome: case-based review. Rheumatol Int. 2021;41(6):1175–1181. doi:10.1007/s00296-021-04820-8.
  • Ozel L, Unal A, Unal E, et al. Granulomatous mastitis: is it an autoimmune disease? Diagnostic and therapeutic dilemmas. Surg Today. 2012;42(8):729–733. doi:10.1007/s00595-011-0046-z.
  • Asoglu O, Ozmen V, Karanlik H, et al. Feasibility of surgical management in patients with granulomatous mastitis. Breast J. 2005;11(2):108–114. doi:10.1111/j.1075-122X.2005.21576.x.
  • Erhan Y, Veral A, Kara E, et al. A clinicopthologic study of a rare clinical entity mimicking breast carcinoma: idiopathic granulomatous mastitis. Breast. 2000;9(1):52–56. doi:10.1054/brst.1999.0072.
  • Ren XC, Huang YP, Wu LJ, Qiu LL, Zhao ZQ. Clinical pathology and cytological analysis of granulomatous lobular mastitis. Zhejiang Clinical Medical Journal. 2004;6:905–906. doi:10.3969/j.issn.1008-7664.2004.10.060. (In Chinese)
  • Huang B, Han L, Zhao YY. The clinical pathobiology feature of granulomatous lobular mastitis. J Mod Oncol. 2007;15:334–335. doi:10.3969/j.issn.1672-4992.2007.03.014. (In Chinese)
  • Yang XH. The relative study of expression of IL-2-IL-4 in the tissue of GM [Thesis]. [Shandong, China]: Shandong University of Traditional Chinese Medicine; 2010.
  • Diao Y, Shan CY, Zhao Y, et al. Role of IL-6/STAT3 signaling pathway in the granulomatous mastitis. Prog Mod Biomed. 2018;18:4486–4488. doi:10.13241/j.cnki.pmb.2018.23.020. (In Chinese)
  • Koksal H, Vatansev H, Artac H, Kadoglou N. The clinical value of interleukins-8, -10, and -17 in idiopathic granulomatous mastitis. Clin Rheumatol. 2020;39(5):1671–1677. doi:10.1007/s10067-020-04925-8.
  • Zhang Y, Zhang Y, Gu W, Sun B. TH1/TH2 cell differentiation and molecular signals. Adv Exp Med Biol. 2014;841:15–44. doi:10.1007/978-94-017-9487-9_2.
  • Liu L. The investigation of the etiology and antituberculous therapy for non-puerperal matitis [Dissertation]. [Shandong, China]: Shandong University; 2017.
  • Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000;100(6):655–669. doi:10.1016/S0092-8674(00)80702-3.
  • Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009;30(5):646–655. doi:10.1016/j.immuni.2009.05.001.
  • Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH. Pillars article: a novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000. 100: 655–669. J Immunol. 2015;194(7):2961–2975. doi:10.1016/S0092-8674(00)80702-3.
  • Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin Immunol. 2015;34:130–136. doi:10.1016/j.coi.2015.03.007.
  • Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 2001;14(3):205–215. doi:10.1016/S1074-7613(01)00103-0.
  • Barbi J, Pardoll D, Pan F. Treg functional stability and its responsiveness to the microenvironment. Immunol Rev. 2014;259(1):115–139. doi:10.1111/imr.12172.
  • Shevyrev D, Tereshchenko V. Treg heterogeneity, function, and homeostasis. Front Immunol. 2019;10:3100. doi:10.3389/fimmu.2019.03100.
  • Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate IFNG and silence Il4 in T helper type 1 cells. Nat Immunol. 2007;8(2):145–153. doi:10.1038/ni1424.
  • Bao Y, Peng J, Yang KL, et al. Therapeutic effects of Chinese medicine Di-Long (Pheretima vulgaris) on rheumatoid arthritis through inhibiting NF-κB activation and regulating Th1/Th2 balance. Biomed Pharmacother. 2022;147:112643. doi:10.1016/j.biopha.2022.112643.
  • Muhammad Yusoff F, Wong KK, Mohd Redzwan N. Mohd Redzwan N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity. 2020;53(1):8–20. doi:10.1080/08916934.2019.1693545.
  • Xia Y, Chen H. The investigation of liver-discharging and heat-clearing therapy to regulate the balance of Th1/Th2 cells in non-lactation mastitis. Medical Information. 2012;25:103–104. doi:10.3969/j.issn.1006-1959.2012.02.096. (In Chinese)
  • Yang XH, Shi Y, Shi H, Yang TZ. Expression and clinical significance of IL-2 and IL-4 in pathological tissues of granulomatous mastitis. Chin Rem Clin. 2021;21:908–910. doi:10.11655/zgywylc2021.06.003. (In Chinese)
  • Wang YY. To Investigate the Expression of IL-6, IL-1β, and IFN-Γ in the Effect of Yiqiheying on the Immune Imbalance in the Mass Stage [Thesis]. [Shandong, China]: Shandong University of Traditional Chinese Medicin; 2020.
  • Ding XB. Efficacy of lesions resection and conservative antibiotics in granulomatous mastitis and effect on serum interleukin-2 and interleukin-4 levels. Matern Child Health Care China. 2017;32(21):5290–5291. doi:10.7620/zgfybj.j.issn.1001-4411.2017.21.38. (In Chinese)
  • Idriss HT, Naismith JT. TNFα and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000;50(3):184–195. doi:10.1002/1097-0029(20000801)50:3 < 184::AID-JEMT2 > 3.0.CO;2-H.
  • Ruterbusch M, Pruner KB, Shehata L, Pepper M. In vivo CD4(+) T cell differentiation and function: revisiting the Th1/Th2 paradigm. Annu Rev Immunol. 2020;38:705–725. doi:10.1146/annurev-immunol-103019-085803.
  • Yang C, Yang M, Wang G, Li Y, Lei Z, Li L. TNF-α induced apoptosis and necroptosis in mouse mammary epithelial cells. J Nanjing Agric Univ. 2022;45:1–10. doi:10.7685/jnau.202102008. (In Chinese)
  • Silva DAAd, Silva MVd, Barros CCO, et al. TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines. PLoS ONE. 2018;13(3):e0194430. doi:10.1371/journal.pone.0194430.
  • Amber KT, Bloom R, Mrowietz U, Hertl M. TNF-α: a treatment target or cause of sarcoidosis. J Eur Acad Dermatol Venereol. 2015;29(11):2104–2111. doi:10.1111/jdv.13246.
  • Zhang CJ, Kong C. Immunological studies about the progress of non-lactating mastitis. J Dalian Med Univ. 2014;36:307–313. doi:10.11724/jdmu.2014.04.01. (In Chinese)
  • Liu X, Wang N, Li F, Song A, Zhang L. Expressions and clinical significance of immune-related factors in different TCM syndrome patterns of granulomatous mastitis. Acta Chin Med Pharmacol. 2020;48:23–28. doi:10.19664/j.cnki.1002-2392.200063. (In Chinese)
  • Guo Y, Wang B, Wang T, et al. Biological characteristics of IL-6 and related intestinal diseases. Int J Biol Sci. 2021;17(1):204–219. doi:10.7150/ijbs.51362.
  • Zhao Y, Wang X, Zhang S, Kang HF, Guan HT, et al. Study of PI3K/AKT/mTOR pathway and immunoglobulin in the pathogenesis of granulomatous lobular mastitis. China Med Her. 2018;15:8–10. doi:CNKI:SUN:YYCY.0.2018-30-003. (In Chinese)
  • Yuan S, Li T, Tang R, Zhang S, Li C, Zhang W. Clinical study of inflammation causing effect of prolactin on granulomatous lobular mastitis patients. Chongqing Med J. 2021;50:30–33. doi:10.3969/j.issn.1671-8348.2021.01.007. (InChinese)
  • Vieira Borba V, Shoenfeld Y. Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding. Clin Rheumatol. 2019;38(5):1263–1270. doi:10.1007/s10067-018-04415-y.
  • Nikolaev A, Blake CN, Carlson DL. Association between hyperprolactinemia and granulomatous mastitis. Breast J. 2016;22(2):224–231. doi:10.1111/tbj.12552.
  • Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin and autoimmunity. Front Immunol. 2018;9:73. doi:10.3389/fimmu.2018.00073.
  • Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol. 2020;16(6):335–345. doi:10.1038/s41584-020-0419-z.
  • Gupta S, Wang W, Hayek SS, STOP-COVID Investigators, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med. 2021;181(1):41–51. doi:10.1001/jamainternmed.2020.6252.
  • Ohue Y, Nishikawa H. Regulatory T (Treg) cells in cancer: can Treg cells be a new therapeutic target. Cancer Sci. 2019;110(7):2080–2089. doi:10.1111/cas.14069.
  • Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med. 2014;20(1):62–68. doi:10.1038/nm.3432.
  • Amatya N, Garg AV, Gaffen SL. IL-17 signaling: the Yin and the Yang. Trends Immunol. 2017;38(5):310–322. doi:10.1016/j.it.2017.01.006.
  • Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989;170(6):2081–2095. doi:10.1084/jem.170.6.2081.
  • Saraiva M, Vieira P, Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217(1):e20190418. doi:10.1084/jem.20190418.
  • Saydam M, Yilmaz KB, Sahin M, et al. New findings on autoimmune etiology of idiopathic granulomatous mastitis: serum IL-17, IL-22 and IL-23 levels of patients. J Invest Surg. 2021;34(9):993–997. doi:10.1080/08941939.2020.1725190.
  • Hoeppli RE, Wu D, Cook L, Levings MK. The environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol. 2015;6:61. doi:10.3389/fimmu.2015.00061.
  • Ucaryilmaz H, Koksal H, Emsen A, Kadoglou N, Dixon JM, Artac H. The role of regulatory T and B cells in the etiopathogenesis of idiopathic granulomatous mastitis. Immunol Invest. 2022;51(2):357–367. doi:10.1080/08820139.2020.1832114.
  • Guerrero-Zotano A, Mayer IA, Arteaga CL. PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment. Cancer Metastasis Rev. 2016;35(4):515–524. doi:10.1007/s10555-016-9637-x.
  • Li S, Fan Q, He S, Tang T, Liao Y, Xie J. MicroRNA-21 negatively regulates Treg cells through a TGF-β1/Smad-independent pathway in patients with coronary heart disease. Cell Physiol Biochem. 2015;37(3):866–878. doi:10.1159/000430214.
  • Chen L, Gao D, Shao Z, Zheng Q, Yu Q. miR-155 indicates the fate of CD4(+) T cells. Immunol Lett. 2020;224:40–49. doi:10.1016/j.imlet.2020.05.003.
  • Aksan H, Kundaktepe BP, Sayili U, et al. Circulating miR-155, let-7c, miR-21, and PTEN levels in differential diagnosis and prognosis of idiopathic granulomatous mastitis and breast cancer. Biofactors. 2020;46(6):955–962. doi:10.1002/biof.1676.